|Table of Contents|

Silencing EMI2 gene inhibits proliferation and epithelied-mesenchymal transformation of intrahepatic cholangiocarcinoma HuCCT1 cells

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2022 03
Page:
389-395
Research Field:
Publishing date:

Info

Title:
Silencing EMI2 gene inhibits proliferation and epithelied-mesenchymal transformation of intrahepatic cholangiocarcinoma HuCCT1 cells
Author(s):
ZHOU Shuai1QU Kanglin1SU Lili2CHEN Shilei1LI Jinang1JIN Hao3WANG Yong3PANG Qing1LIU Huichun1
1.Department of Hepatobiliary Surgery;2.Department of Oncology,the First Affiliated Hospital of Bengbu Medical College,Anhui Bengbu 233000,China;3.The Fourth Department of General Surgery,the Second People's Hospital of Anhui Province,Anhui Hefei 230000,China.
Keywords:
early mitotic suppressor 2intrahepatic cholangiocarcinomaproliferationepithelial-mesenchymal transformationinvasionmigration
PACS:
R735.8
DOI:
10.3969/j.issn.1672-4992.2022.03.005
Abstract:
Objective:To explore the expression and biological function of early mitotic inhibitor 2(EMI2) in intrahepatic cholangiocarcinoma(iCCA) tissues.To investigate the effects of EMI2 on the proliferation,invasion and epithelial-mesenchymal transformation of iCCA cells HuCCT1.Methods:Bioinformatics technique was used to detect the expression of EMI2 in bile duct carcinoma.Gene silencing technique was used to silence EMI2,and its effects on proliferation,invasion,migration and EMT of HuCCT1 cells were observed.Results:Bioinformatics showed that EMI2 was highly expressed in cholangiocarcinoma tissues,while Western Blot and RT-PCR were ineffective in detecting EMI2.CCK-8 showed that the OD450 value of shEMI2 group was lower than that of shCtrol group(P<0.05),and the number of shEMI2 cell clone formation(26±2) was lower than that of shCtrol group(57±4).Invasive results showed that the number of invasion in shEMI2 group was (39±4.92) and in shCtrol group was (195±14.00).Cell cycle test showed that compared with shCtrol group,shEMI2 group of G2/M cells decreased and G1 cells increased(P<0.05).The apoptosis experiment showed that the apoptosis rate of shEMI2 group was increased(P<0.05).Western Blot and immunofluorescence results suggested that silencing EMI2 could promote the up-regulation of E-cadherin protein and down-regulation of N-cadherin and Vitmentin protein.Conclusion:Silencing EMI2 gene inhibites the proliferation,invasion,migration and epithelied-mesenchymal transformation of intrahepatic cholangiocarcinoma.

References:

[1] MOEINI A,SIA D,BARDEESY N,et al.Molecular pathogenesis and targeted therapies for intrahepatic cholangiocarcinoma[J].Clin Cancer Res,2016,22(2):291-300.
[2] KE Q,LIN N,DENG M,et al.The effect of adjuvant therapy for patients with intrahepatic cholangiocarcinoma after surgical resection:A systematic review and meta-analysis[J].PLoS One,2020,15(2):e0229292.
[3] SIRICA AE,GORES GJ,GROOPMAN JD,et al.Intrahepatic cholangiocarcinoma:Continuing challenges and translational advances[J].Hepatology,2019,69(4):1803-1815.
[4] 尤文化,梁渊,吕凌.精准医学时代下肝内胆管癌的发病机制与临床转化[J].临床肝胆病杂志,2021,37(04):935-938. YOU Wenhua,LIANG Yuan,LYU Ling.Pathogenesis and clinical transformation of intrahepatic cholangiocarcinoma in the era of precision medicine[J].Journal of Clinical Hepatobiliary Diseases,2021,37(04):935-938.
[5] JIN J,CARDOZO T,LOVERING RC,et al.Systematic analysis and nomenclature of mammalian F-box proteins[J].Genes Dev,2004,18(21):2573-2580.
[6] SCHMIDT A,DUNCAN PI,RAUH NR,et al.Xenopus polo-like kinase Plx1 regulates XErp1,a novel inhibitor of APC/C activity[J].Genes Dev,2005,19(4):502-513.
[7] NAKAYAMA KI,NAKAYAMA K.Ubiquitin ligases:cell-cycle control and cancer[J].Nat Rev Cancer,2006,6(5):369-381.
[8] XU B,LYU W,LI X,et al.Prognostic genes of hepatocellular carcinoma based on gene coexpression network analysis[J].J Cell Biochem,2019,120(7):11616-11623.
[9] HEIM A,TISCHER T,MAYER TU.Calcineurin promotes APC/C activation at meiotic exit by acting on both XErp1 and Cdc20[J].EMBO Rep,2018,19(12):e46433.
[10] OHE M,KAWAMURA Y,UENO H,et al.Emi2 inhibition of the anaphase-promoting complex/cyclosome absolutely requires Emi2 binding via the C-terminal RL tail[J].Mol Biol Cell,2010,21(6):905-913.
[11] SIEGEL RL,MILLER KD,JEMAL A.Cancer statistics,2020[J].CA Cancer J Clin,2020,70(1):7-30.
[12] YU Y,LIU Q,LI W,et al.Identification of a novel EHBP1-MET fusion in an intrahepatic cholangiocarcinoma responding to crizotinib[J].Oncologist,2020,25(12):1005-1008.
[13] WARDELL CP,FUJJTA M,YAMADA T,et al.Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations[J].J Hepatol,2018,68(5):959-969.
[14] TATE JG,BAMFORD S,JUBB HC,et al.COSMIC:the catalogue of somatic mutations in cancer[J].Nucleic Acids Res,2019,47(D1):D941-D947.
[15] BOONSRI B,YACQUB-USMAN K,THINTHARUA P,et al.Effect of combining EGFR tyrosine kinase inhibitors and cytotoxic agents on cholangiocarcinoma cells[J].Cancer Res Treat,2021,53(2):457-470.
[16] LAMBERTI D,CRISTINZIANO G,PORRU M,et al.HSP90 inhibition drives degradation of FGFR2 fusion proteins:Implications for treatment of cholangiocarcinoma[J].Hepatology,2019,69(1):131-142.
[17] MADGWICK S,JONES KT.How eggs arrest at metaphase Ⅱ:MPF stabilisation plus APC/C inhibition equals cytostatic factor[J].Cell Div,2007,2:4.
[18] JANG SH,KIM AR,PARK NH,et al.DRG2 regulates G2/M progression via the Cyclin B1-Cdk1 complex[J].Mol Cells,2016,39(9):699-704.
[19] GOPINATHAN L,SZMYD R,LOW D,et al.Emi2 is essential for mouse spermatogenesis[J].Cell Rep,2017,20(3):697-708.
[20] 邓刚,蔡谭兴,雷钊,等.SALL4基因在肝内胆管癌中通过抑制KLF4基因表达促进EMT改变[J].肿瘤药学,2021,11(01):36-39. DENG Gang,CAI Tanxing,LEI Zhao,et al.SALL4 gene promotes EMT by inhibiting KLF4 gene expression in intrahepatic cholangiocarcinoma[J].Oncology Pharmacy,2021,11(01):36-39.
[21] 周闯,陆旭,宋盛平,等.PKM2对肝内胆管癌细胞增殖及上皮间质化的影响[J].西安交通大学学报(医学版),2021,42(01):25-29. ZHOU Chuang,LU Xu,SONG Shengping,et al.Effect of PKM2 on proliferation and epithelial-mesenchymal differentiation of intrahepatic bile duct cancer cells[J].Journal of Xi'an Jiaotong University(Medical Science Edition),2021,42(01):25-29.
[22] PAN S,HU Y,HU M,et al.Platelet-derived PDGF promotes the invasion and metastasis of cholangiocarcinoma by upregulating MMP2/MMP9 expression and inducing EMT via the p38/MAPK signalling pathway[J].Am J Transl Res,2020,12(7):3577-3595.
[23] ZHAO H,DESAI V,WANG J,et al.Epithelial-mesenchymal transition predicts sensitivity to the dual IGF-1R/IR inhibitor OSI-906 in hepatocellular carcinoma cell lines[J].Mol Cancer Ther,2012,11(2):503-513.
[24] CHEN T,LI K,LIU Z,et al.WDR5 facilitates EMT and metastasis of CCA by increasing HIF-1α accumulation in Myc-dependent and independent pathways[J].Mol Ther,2021,29(06):2134-2150.
[25] SUWANNAKUL N,MA N,MIDORIKAWA K,et al.CD44v9 induces stem cell-like phenotypes in human cholangiocarcinoma[J].Front Cell Dev Biol,2020,8:417.

Memo

Memo:
安徽省自然科学基金杰出青年基金(编号:2008085J37);蚌埠医学院研究生科研创新计划基金(编号:Byycx20032)
Last Update: 2021-12-31